← Back to Search

Behavioral Intervention

RESToRE for Long COVID Syndrome (RESToRE Trial)

N/A
Recruiting
Led By Anna Norweg, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights

RESToRE Trial Summary

This trial will investigate if aerobic/breathing exercises can help people with long COVID. Participants will do a tailored 6-week home exercise program supervised by therapists.

Who is the study for?
This trial is for individuals experiencing long COVID, specifically those with post-COVID syndrome or exercise intolerance. Participants should be able to follow a home exercise program for 6 weeks and commit to sessions 5-6 days per week.Check my eligibility
What is being tested?
The study is testing if rehabilitation exercises can aid recovery from long COVID. It compares two types of exercises: aerobic rehabilitation and light stretching/breathing exercises, both supervised by therapists.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include typical reactions to new exercise routines such as muscle soreness, fatigue, or shortness of breath within the limits of sub-symptom threshold activity.

RESToRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants who adhered to session attendance
Number of participants who completed
Number of participants who enrolled
Secondary outcome measures
EuroQol: Education Quotient-5D Visual Analogue Scale score
General Symptom Questionnaire (SGQ-30) score
Global Change Assessment (GCA) score
+5 more

RESToRE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RESToREExperimental Treatment1 Intervention
Participants will receive RESToRE, an interdisciplinary, hybrid 8- week intervention.
Group II: Light Stretching ExerciseActive Control1 Intervention
The control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician.

Find a Location

Who is running the clinical trial?

New York UniversityOTHER
226 Previous Clinical Trials
314,235 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,811 Total Patients Enrolled
Anna Norweg, PhDPrincipal InvestigatorColumbia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the magnitude of people enrolled in this experiment?

"Affirmative. Clinicaltrials.gov indicates that this trial is still open for recruitment, having been initially posted on October 1st 2023 and last updated on December 14th 2023. Currently, the study needs to find 20 volunteers at a single location."

Answered by AI

Is the study open to those of advanced age?

"To qualify for this medical trial, one must be aged 18 to 70. Additionally, there are 11 trials specifically designed for minors and 127 clinical studies targeting senior citizens."

Answered by AI

Is this research project recruiting participants at present?

"Affirmative, the information on clinicaltrials.gov demonstrates that this medical trial is actively enrolling participants. It was first posted on October 1st 2023 and has since been updated on December 14th with a goal of recruiting 20 patients from one site."

Answered by AI

Is it possible for me to become part of this experiment?

"To become eligible for this trial, applicants must be afflicted with long covid syndrome and within the age range of 18-70. Approximately 20 patients are needed to participate in the program."

Answered by AI

What are the primary objectives of this clinical investigation?

"The primary outcome for this 10-week medical trial is the total number of participants who completed. Secondary outcomes include PROMIS-29 scale score (1-5, higher scores indicating worse quality of life), Rand 36-Item Health Survey (SF-36) score (1-6, higher scores correlating with poorer health outcomes), and General Symptom Questionnaire (SGQ30) score(0 - 4, greater values pointing to severe symptomology)."

Answered by AI
~13 spots leftby Apr 2025